Insider Transactions in Q2 2025 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 07
2025
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.15%
|
$7,000
$1.01 P/Share
|